Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Noel

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Bone Marrow Transplantation|May 26, 2018
Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosisTania Jain, Katie L Kunze, M'hamed Temkit, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 14, 2018
Treatment With Bortezomib-based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective StudyTania Jain, Heidi E Kosiorek, Shu T Kung, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 1, 2021
Case Report: Two Cases of Cryptosporidiosis in Heavily Pretreated Patients With MyelomaJordane Demonchy, Camille Cordier, Emilie Fréalle, et al.
The Journal of Allergy and Clinical Immunology|March 4, 2014
Mastocytosis associated with a rare germline KIT K509I mutation displays a well-differentiated mast cell phenotypeEunice Ching Chan, Yun Bai, Arnold S Kirshenbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid LeukemiaGabriel Etienne, Joëlle Guilhot, Delphine Rea, et al.
Blood Cancer Journal|March 12, 2020
Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosisTania Jain, Katie L Kunze, Luke Mountjoy, et al.
Leukemia Research|May 15, 2012
Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phaseChad Cherington, James L Slack, Jose Leis, et al.
Blood|July 10, 2010
Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexisDavid H McDermott, Suk See De Ravin, Hyun Sik Jun, et al.
Cancer|August 14, 2014
IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myelomaEileen M Boyle, Guillemette Fouquet, Stéphanie Guidez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancyClaude Sportès, Rebecca R Babb, Michael C Krumlauf, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Bone Marrow Transplantation|May 26, 2018
Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosisTania Jain, Katie L Kunze, M'hamed Temkit, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 14, 2018
Treatment With Bortezomib-based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective StudyTania Jain, Heidi E Kosiorek, Shu T Kung, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 1, 2021
Case Report: Two Cases of Cryptosporidiosis in Heavily Pretreated Patients With MyelomaJordane Demonchy, Camille Cordier, Emilie Fréalle, et al.
The Journal of Allergy and Clinical Immunology|March 4, 2014
Mastocytosis associated with a rare germline KIT K509I mutation displays a well-differentiated mast cell phenotypeEunice Ching Chan, Yun Bai, Arnold S Kirshenbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid LeukemiaGabriel Etienne, Joëlle Guilhot, Delphine Rea, et al.
Blood Cancer Journal|March 12, 2020
Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosisTania Jain, Katie L Kunze, Luke Mountjoy, et al.
Leukemia Research|May 15, 2012
Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phaseChad Cherington, James L Slack, Jose Leis, et al.
Blood|July 10, 2010
Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexisDavid H McDermott, Suk See De Ravin, Hyun Sik Jun, et al.
Cancer|August 14, 2014
IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myelomaEileen M Boyle, Guillemette Fouquet, Stéphanie Guidez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancyClaude Sportès, Rebecca R Babb, Michael C Krumlauf, et al.
Pageof 7